Frazier Financial Advisors’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$434 Buy
+9
New +$460 ﹤0.01% 736
2026
Q2
– Sell
-21
Closed -$1.16K – 715
2026
Q1
$1.16K Sell
21
-59
-74% -$3.2K ﹤0.01% 609
2025
Q4
$3.92K Buy
+80
New +$3.73K ﹤0.01% 497
2024
Q4
– Sell
-215
Closed -$8.79K – 748
2024
Q3
$8.79K Sell
215
-259
-55% -$10.6K 0.01% 404
2024
Q2
$18.2K Buy
474
+239
+102% +$10.1K 0.01% 309
2024
Q1
$10.1K Buy
235
+177
+305% +$7.3K 0.01% 410
2023
Q4
$2.15K Buy
+58
New +$2.08K ﹤0.01% 665

Other funds holding GSK

Frazier Financial Advisors's GSK Position: Q3 2026 in Review

Frazier Financial Advisors opened a new position in GSK (GSK) in Q3 2026: 9 shares worth $434. The stake represents ﹤0.01% of the portfolio and ranks #736 among its holdings. This is a return to the name: Frazier Financial Advisors previously reported a position in GSK as recently as Q1 2026.

Frazier Financial Advisors first reported a position in GSK in Q4 2023 and has held it in 7 quarters since. The position peaked at $18.2K in Q2 2024. 986 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Frazier Financial Advisors held 9 shares of GSK worth $434 as of Q3 2026.
  • GSK was a new Frazier Financial Advisors position in Q3 2026.
  • GSK made up ﹤0.01% of Frazier Financial Advisors's portfolio in Q3 2026, its #736 holding.
  • Frazier Financial Advisors first reported a position in GSK in Q4 2023 and has held it in 7 quarters since.
  • Frazier Financial Advisors's GSK position peaked at $18.2K in Q2 2024.
  • 986 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Frazier Financial Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.